| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/23/2011 | CA2784783A1 Organic compositions to treat hsf1-related diseases |
| 06/23/2011 | CA2784599A1 Methods for producing polypeptides in protease-deficient mutants of trichoderma |
| 06/23/2011 | CA2784500A1 Anti-thrombosis aptamers and method for stabilizing the structure thereof |
| 06/23/2011 | CA2784252A1 Dicer substrate agents and methods for the specific inhibition of gene expression |
| 06/23/2011 | CA2784050A1 C. histolyticum recombinant collagenases and method for the manufacture thereof |
| 06/23/2011 | CA2783510A1 Production of ifn-lambda by conventional dendritic cells and uses thereof |
| 06/23/2011 | CA2782977A1 Tmem22 peptides and vaccines including the same |
| 06/23/2011 | CA2782093A1 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
| 06/23/2011 | CA2778872A1 A method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands |
| 06/23/2011 | CA2778871A1 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
| 06/22/2011 | EP2336778A1 Compositions and methods for treating lung cancer |
| 06/22/2011 | EP2336775A2 High affinity TCR proteins and methods |
| 06/22/2011 | EP2336772A1 Methods for predicting pregnancy outcome in a subject by HCG assay |
| 06/22/2011 | EP2336768A1 Method for assaying protein-protein interaction |
| 06/22/2011 | EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/22/2011 | EP2336367A1 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1 |
| 06/22/2011 | EP2336366A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/22/2011 | EP2336365A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/22/2011 | EP2336364A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/22/2011 | EP2336363A1 MicroRNAs and uses thereof |
| 06/22/2011 | EP2336362A1 Use of CRISPR associated genes (cas) |
| 06/22/2011 | EP2336359A1 1L1RL-1 as a cardiovascular disease marker and therapeutic target |
| 06/22/2011 | EP2336347A1 Microorganism capable of producing l-amino acid, and method for producing l-amino acid |
| 06/22/2011 | EP2336339A2 Production of viral vectors |
| 06/22/2011 | EP2336338A2 Transgenic non-human animals for pharmacological and toxicological studies |
| 06/22/2011 | EP2336337A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 06/22/2011 | EP2336336A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 06/22/2011 | EP2336335A2 Biologically safe transient protein expression in plants |
| 06/22/2011 | EP2336334A1 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 06/22/2011 | EP2336333A1 Methods and materials for conferring resistance to pests and pathogens of plants |
| 06/22/2011 | EP2336332A2 Genes and uses for plant enhancement |
| 06/22/2011 | EP2336331A1 Novel proteases and variants thereof |
| 06/22/2011 | EP2336330A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 06/22/2011 | EP2336329A1 Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenis human idiotype antibodies |
| 06/22/2011 | EP2336328A1 Method for isolation of soluble polypeptides |
| 06/22/2011 | EP2336327A1 Method for isolation of soluble polypeptides |
| 06/22/2011 | EP2336326A2 Method for isolation of soluble polypeptides |
| 06/22/2011 | EP2336325A1 Method for isolation of soluble polypeptides |
| 06/22/2011 | EP2336324A2 Method for isolation of soluble polypeptides |
| 06/22/2011 | EP2336323A2 Method for isolation of soluble polypeptides |
| 06/22/2011 | EP2336322A1 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336320A1 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions |
| 06/22/2011 | EP2336319A1 Antisense modulation of apolipoprotein B expression |
| 06/22/2011 | EP2336318A1 Antisense modulation of apolipoprotein B expression |
| 06/22/2011 | EP2336317A1 Double-stranded ribonucleic acid with increased effectiveness in an organism |
| 06/22/2011 | EP2336316A1 Method of diagnosing small cell lung cancer |
| 06/22/2011 | EP2336315A2 Enzymatic encoding methods for efficient synthesis of large libraries |
| 06/22/2011 | EP2336314A1 Improved selex and photoselex |
| 06/22/2011 | EP2336313A1 Methods for production of proteins |
| 06/22/2011 | EP2336312A1 Triterpene oxidase derived from glychyrrhiza plant, gene encoding the oxidase, and method for utilizing the gene |
| 06/22/2011 | EP2336311A1 Anti-tuna vasa antibody |
| 06/22/2011 | EP2336309A2 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 06/22/2011 | EP2336308A2 Enzymes for starch processing |
| 06/22/2011 | EP2336307A1 Isolated plant GDSL lipase |
| 06/22/2011 | EP2336305A2 Cloning of cytochrome P450 genes from Nicotiana |
| 06/22/2011 | EP2336302A1 Nucleotide sequence encoding the enzyme I-sceI and the uses thereof |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/22/2011 | EP2336295A1 Method for producing lactic acid from plant-derived raw material, and lactic-acid-producing bacterium |
| 06/22/2011 | EP2336190A2 Anti-VEGF antibodies |
| 06/22/2011 | EP2336186A1 Humanized antibodies against ICAM-1, their production and uses |
| 06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
| 06/22/2011 | EP2336179A1 Stabilized single domain antibodies |
| 06/22/2011 | EP2336175A1 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 06/22/2011 | EP2336173A1 Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same |
| 06/22/2011 | EP2336171A1 Novel targets for the treatment of proliferative diseases |
| 06/22/2011 | EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
| 06/22/2011 | EP2336166A1 Compositions that inhibit proliferation of cancer cells |
| 06/22/2011 | EP2336154A2 Agent that modulates physiological condition of pests, involved in insect vesicle-fusing atpase activity |
| 06/22/2011 | EP2336153A1 Improved expression systems with SEC-system secretion |
| 06/22/2011 | EP2336151A1 Replikin peptides and uses thereof |
| 06/22/2011 | EP2336150A2 Replikin peptides and uses thereof |
| 06/22/2011 | EP2336148A1 Compositions and methods for use in recombinational cloning of nucleic acids |
| 06/22/2011 | EP2336145A1 Antisense modulation of apolipoprotein B expression |
| 06/22/2011 | EP2335730A1 Fusion polypeptides and their use for prevention and treatment of cancer |
| 06/22/2011 | EP2335728A1 Specific binding proteins and uses thereof |
| 06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
| 06/22/2011 | EP2335724A1 Immunisation against chlamydia trachomatis |
| 06/22/2011 | EP2335723A1 Immunisation against chlamydia trachomatis |
| 06/22/2011 | EP2335718A1 Non-cytotoxic protein conjugates |
| 06/22/2011 | EP2335687A2 Use of monoolein as a new auxiliary lipid in lipofection |
| 06/22/2011 | EP2335501A1 Phytase-containing animal food and method |
| 06/22/2011 | EP2334819A2 Transcription factor decoys |
| 06/22/2011 | EP2334806A1 Method for identifying gene-activating active substances |
| 06/22/2011 | EP2334802A1 Methods of generating gene specific libraries |
| 06/22/2011 | EP2334798A2 Glutamate decarboxylase (gad) transgenic plants that exhibit altered plant architecture |
| 06/22/2011 | EP2334797A1 Plants having enhanced yield-related traits and a method for making the same |
| 06/22/2011 | EP2334796A1 Importation of a ribozyme into vegetable mitochondria by a pseudo-trna that can be aminoacylated by valine |
| 06/22/2011 | EP2334795A1 Compositions and methods for expression of a heterologous nucleotide sequence in plants |
| 06/22/2011 | EP2334794A2 Modulation of bcl11a for treatment of hemoglobinopathies |
| 06/22/2011 | EP2334793A1 Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene |
| 06/22/2011 | EP2334792A2 Matrices and media for storage and stabilization of biomolecules |
| 06/22/2011 | EP2334791A1 Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase |
| 06/22/2011 | EP2334790A1 Pancreatic cancer related gene ttll4 |
| 06/22/2011 | EP2334789A1 Breast cancer related gene rqcd1 |